Christophe Severin

748 total citations
8 papers, 582 citations indexed

About

Christophe Severin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Christophe Severin has authored 8 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Hepatology. Recurrent topics in Christophe Severin's work include Liver physiology and pathology (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Axon Guidance and Neuronal Signaling (2 papers). Christophe Severin is often cited by papers focused on Liver physiology and pathology (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Axon Guidance and Neuronal Signaling (2 papers). Christophe Severin collaborates with scholars based in United States and Switzerland. Christophe Severin's co-authors include Jiping Zha, Robert L. Yauch, Nerissa Mendoza, Somasekar Seshagiri, Dineli Wickramasinghe, Linda Rangell, Kanan Pujara, Thomas Holcomb, Kaumudi Bhawe and Ling Fu and has published in prestigious journals such as Development, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Christophe Severin

7 papers receiving 566 citations

Peers

Christophe Severin

MB

PRM

HEPAT

ONCOL

PFM

Carrie R. Graveel United States

Virna Cepero Italy

Purnima K. Wagh United States

Linquan Wu China

Jennie Hauser United States

Annalisa Chiriatti Italy

Alan Ka‐Lun Kai Hong Kong

Kai‐Yu Ng Hong Kong

Hong-Jen Lee Taiwan

Genfu Yao China

Carrie R. Graveel United States

Christophe Severin

419 ×1.2

MB

86 ×0.4

PRM

65 ×0.3

HEPAT

201 ×1.6

ONCOL

51 ×0.6

PFM

Citations per year, relative to Christophe Severin Christophe Severin (= 1×) peers Carrie R. Graveel

Countries citing papers authored by Christophe Severin

Since Specialization

Citations

This map shows the geographic impact of Christophe Severin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Severin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Severin more than expected).

Fields of papers citing papers by Christophe Severin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Severin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Severin. The network helps show where Christophe Severin may publish in the future.

Co-authorship network of co-authors of Christophe Severin

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Severin. A scholar is included among the top collaborators of Christophe Severin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Severin. Christophe Severin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Kanouni, Toufike, Christophe Severin, Natalie Yuen, et al.. (2020). Discovery of CC-90011: A Potent and Selective Reversible Inhibitor of Lysine Specific Demethylase 1 (LSD1). Journal of Medicinal Chemistry. 63(23). 14522–14529. 92 indexed citations

2.

Severin, Christophe, et al.. (2020). DDRE-26. TARGETING THE UNFOLDED PROTEIN RESPONSE POTENTIATES MARIZOMIB ANTITUMOR ACTIVITY IN GLIOBLASTOMA. Neuro-Oncology. 22(Supplement_2). ii67–ii67.

3.

Nie, Zhe, Lihong Shi, Chon Lai, et al.. (2018). Structure-based design and discovery of potent and selective lysine-specific demethylase 1 (LSD1) inhibitors. Bioorganic & Medicinal Chemistry Letters. 29(1). 103–106. 12 indexed citations

4.

Mai, Elaine, Zhong Zheng, Youjun Chen, et al.. (2013). Nonclinical Evaluation of the Serum Pharmacodynamic Biomarkers HGF and Shed MET following Dosing with the Anti-MET Monovalent Monoclonal Antibody Onartuzumab. Molecular Cancer Therapeutics. 13(2). 540–552. 10 indexed citations

5.

Zhang, Yuwen, Yanli Su, Sharianne G. Louie, et al.. (2008). Combination efficacy with MetMAb and erlotinib in a NSCLC tumor model highlight therapeutic opportunities for c-Met inhibitors in combination with EGFR inhibitors. Cancer Research. 68. 1336–1336. 9 indexed citations

6.

Kong-Beltran, Monica, Somasekar Seshagiri, Jiping Zha, et al.. (2006). Somatic Mutations Lead to an Oncogenic Deletion of Met in Lung Cancer. Cancer Research. 66(1). 283–289. 372 indexed citations

7.

Birgbauer, Eric, Stephen F. Oster, Christophe Severin, & David W. Sretavan. (2001). Retinal axon growth cones respond to EphB extracellular domains as inhibitory axon guidance cues. Development. 128(15). 3041–3048. 58 indexed citations

8.

Zhang, Fan, et al.. (2000). GAP-43 mediates retinal axon interaction with lateral diencephalon cells during optic tract formation. Development. 127(5). 969–980. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact